ABOUT AGILENT TECHNOLOGIES
Agilent is a leader in life sciences, diagnostics, and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise enabling customers to gain the insights they seek. Agilent’s expertise, innovative technology solutions, and trusted collaboration gives them the highest confidence in our solutions.
ANTIBODY FEATURED CONTENT
-
A fast, automated protein analysis workflow empowers researchers to screen yeast strains more efficiently. See how this streamlined approach accelerates innovation while supporting sustainability.
-
Explore a detailed comparison of antibody fragment separation methods that shows how advanced electrophoresis systems closely align with established NIST benchmarks, offering clear resolution.
-
Explore how automated electrophoretic analysis improves protein QC by delivering sharper sizing accuracy, stronger quantitative linearity, and greater consistency than conventional gel workflows.
-
Gain insight into how SEC and CE‑SDS complement each other to assess monoclonal antibody size variants, offering stronger insight into aggregates, fragments, and overall purity.
NGS QC FEATURED CONTENT
-
Take a look at how electrophoresis systems differ in sizing accuracy and why those distinctions matter for assessing high‑molecular‑weight DNA and protecting QC checkpoints across sequencing workflows.
-
Different extraction methods produce dramatically different DNA sizes and qualities, directly affecting long‑read sequencing results. See how performing early QC can improve sequencing success.
-
Learn how precise sizing methods reveal nucleosome patterns in cfDNA and help distinguish true signal from extraction‑related artifacts for more reliable genomic analysis.
-
See how consistent QC checkpoints show how even degraded samples can produce strong sequencing results when monitored with reliable sizing, quantification, and workflow‑specific thresholds.
-
Examine how a molecular genetics team improves NGS efficiency and library quality through streamlined automation, intuitive QC tools, and reliable workflows, boosting reproducibility.
-
See how a leading genomics facility advances long‑read sequencing through rigorous QC and flexible workflows, offering practical insights for researchers aiming to improve sequencing outcomes.
-
Accurately identifying low‑level adapter dimers is key. Compare electrophoresis methods to show how different kits detect and resolve small fragments, helping researchers choose the best QC approach.
-
Accurate sizing of large DNA fragments is crucial in long‑read sequencing. Examine how different electrophoresis methods perform with 10–20 kb smears and how to choose the most reliable approach.
-
Understanding library size distributions helps prevent sequencing through the insert, reducing adapter read‑through. Explore how smear analysis guides optimal read‑length selection to avoid noise.
-
See how automated electrophoresis and key integrity metrics strengthen NGS workflows by improving sample assessment, streamlining QC steps, and supporting confident decisions.
IVT MRNA FEATURED CONTENT
-
Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.
-
Automated capillary electrophoresis provides robust, precise analysis of IVT mRNA integrity, concentration, and size, demonstrating excellent method precision.
-
Discover how an automated capillary electrophoresis system provides robust and precise integrity, concentration, and size analysis for IVT mRNA.
-
Learn best practices for high-resolution analysis of IVT RNA using automated capillary electrophoresis. Improve accuracy and precision in quantifying critical quality attributes.
-
Find out how to achieve reliable IVT mRNA quality. Learn the best practices for precise analysis, including proper sample prep and system optimization for high-resolution results.
-
Accurate sizing and purity checks are essential in IVT RNA workflows. Explore how automated electrophoresis improves QC efficiency and ensures RNA integrity for downstream applications.
-
In vitro transcribed mRNA revolutionizes biotherapeutics, which necessitates thorough quality assessments. See how an analyzer system enhances encapsulation efficiency and CQAs in IVT mRNA workflows.
-
Learn more about issued guidelines on Critical Quality Attributes for IVT mRNA vaccines and biotherapeutics to focus on drug substance and LNP-encapsulated drug product assessment using an analyzer system.
-
Discover how Kaneka Eurogentec, a leading provider of custom DNA synthesis and molecular biology services, enhanced their fragment analysis to achieve higher efficiency and accuracy in their workflows.
-
Discover advanced solutions for IVT RNA synthesis, focusing on enhancing fidelity in throughput, innovative technologies, and methodologies to optimize your RNA research and development processes.
CONTACT INFORMATION
Agilent Technologies
5301 Stevens Creek Blvd.
Santa Clara, CA 95051
UNITED STATES
Phone: +1 877-424-4536
Contact: https://www.agilent.com/en/contact-us/page
AGILENT'S PRIVACY STATEMENT
Click here to view our privacy statement.
ANTIBODY FEATURED PRODUCTS
- Dependable Denaturing Protein Electrophoresis
- A Rapid Workflow For High‑Resolution Protein Analysis
- A Capillary Electrophoresis System That Simplifies Protein Analysis
IVT MRNA FEATURED PRODUCTS
- How It Works: Operation Of Fragment Analyzer Systems
- Development Of COVID-19 Vaccine Production During A Pandemic
- Analysis Kits And Capillary Arrays
- Sample Quality Control (QC) Enhances Vaccine Sample Integrity
- Reliable Results For Nucleic Acid Analysis
- Sample Quality Control For Nucleic Acid-Based Vaccine Development